[6]-Gingerol: A novel AT1 antagonist for the treatment of cardiovascular disease

Planta Medica

Volumn 79, Issue 5, 2013, Pages 322-326

  Liu, Qing ^a   Liu, Jinjin ^b   Guo, Haili ^b   Sun, Shengnan ^b   Wang, Shifeng ^a   Zhang, Yanling ^a   Li, Shiyou ^b   Qiao, Yanjiang ^a  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b Chinese Academy of Sciences and China National Center for Bioinformation   (China)

Author keywords

6 gingerol; AT1 antagonist; calcium assay; cardiovascular disease; Chinese herb; high throughput screening

Indexed keywords

[6] GINGEROL; ANGIOTENSIN II ANTAGONIST; ENDOTHELIN RECEPTOR; GINGEROL; TELMISARTAN; UNCLASSIFIED DRUG; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CATECHOL DERIVATIVE; FATTY ALCOHOL;

ARTICLE; BLOOD PRESSURE REGULATION; CALCIUM MOBILIZATION; CARDIOVASCULAR DISEASE; CELL SURVIVAL; CHINESE HERB; CONTROLLED STUDY; DOSE RESPONSE; GINGER; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; CARDIOVASCULAR DISEASES; CHEMISTRY; DRUG SCREENING; HEK293 CELL LINE; MEDICINAL PLANT;

ZINGIBER OFFICINALE;

ANGIOTENSIN II TYPE 2 RECEPTOR BLOCKERS; CARDIOVASCULAR DISEASES; CATECHOLS; DRUG EVALUATION, PRECLINICAL; FATTY ALCOHOLS; GINGER; HEK293 CELLS; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; PLANTS, MEDICINAL;

EID: 84875752137     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0032-1328262     Document Type: Article

References (29)

1. Karamitsos T. D., Francis J. M., Myerson S., Selvanayagam J. B., Neubauer S. The role of cardiovascular magnetic resonance imaging in heart failure. J Am Coll Cardiol: 2009; 54 1407 1424
2. Lloyd-Jones D., Adams R. J., Brown T. M., Carnethon M., Dai S., De Simone G., Ferguson T. B., Fold E., Furie K., Gillespie C., Go A., Greenlund K., Haase N., Hailpern S., Ho P. M., Howard V., Kissela B., Kittner S., Lackland D., Lisabeth L., Marelli A., McDermott M. M., Meigs J., Mozaffarian D., Mussolino M., Nichol G., Roger V. L., Rosamond W., Sacco R., Sorlie P., Stafford R., Thom T., Wasserthiel-Smoller S., Wong N. D., Wylie-Rosett J. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation: 2010; 121 e46 e215
3. Leal J., Luengo-Fernandez R., Gray A., Petersen S., Rayner M. Economic burden of cardiovascular diseases in the enlarged European Union. Eur Heart J: 2006; 27 1610 1619 (Pubitemid 43954923)
4. de Bekker-Grob E. W., van Dulmen S., van den Berg M., Verheij R. A., Slobbe L. C. Primary prevention of cardiovascular diseases: a cost study in family practices. BMC Fam Pract: 2011; 12 69
5. Drewnowski A., Popkin B. M. The nutrition transition: new trends in the global diet. Nutr Rev: 1997; 55 31 43 (Pubitemid 27220092)
6. Paeratakul S., Popkin B. M., Keyou G., Adair L. S., Stevens J. Changes in diet and physical activity affect the body mass index of Chinese adults. Int J Obes Relat Metab Disord: 1998; 22 424 431 (Pubitemid 28211970)
7. Wildman R. P., Gu D., Muntner P., Wu X., Reynolds K., Duan X., Chen C. S., Huang G., Bazzano L. A., He J. Trends in overweight and obesity in Chinese adults: between 1991 and 1999-2000. Obesity (Silver Spring): 2008; 16 1448 1453 (Pubitemid 351770505)
8. de Gasparo M., Catt K. J., Inagami T., Wright J. W., Unger T. International Union of Pharmacology. XXIII. The Angiotensin II Receptors. Pharmacol Rev: 2000; 52 415 472
9. Timmermans P. B. Pharmacological properties of angiotensin II receptor antagonists. Can J Cardiol: 1999; 15 (Suppl. F) 26F 28F
10. Norris K., Vaughn C. The role of renin-angiotensin-aldosterone system inhibition in chronic kidney disease. Expert Rev Cardiovasc Ther: 2003; 1 51 63
11. Manohar P., Pina I. L. Therapeutic role of angiotensin II receptor blockers in the treatment of heart failure. Mayo Clin Proc: 2003; 78 334 338 (Pubitemid 36259301)
12. Liu Y., Yin H. J., Shi D. Z., Chen K. J. Chinese herb and formulas for promoting blood circulation and removing blood stasis and antiplatelet therapies. Evid Based Complement Alternat Med: 2012; 2012 184503
13. Valli G., Giardina E. G. Benefits, adverse effects and drug interactions of herbal therapies with cardiovascular effects. J Am Coll Cardiol: 2002; 39 1083 1095 (Pubitemid 34267409)
14. Ling S., Dai A., Guo Z., Yan X., Komesaroff P. A. Effects of a Chinese herbal preparation on vascular cells in culture: mechanisms of cardiovascular protection. Clin Exp Pharmacol Physiol: 2005; 32 571 578 (Pubitemid 41021071)
15. Gao D., Song J., Hu J., Lin J., Zheng L., Cai J., Du J., Chen K. Angiogenesis promoting effects of Chinese herbal medicine for activating blood circulation to remove stasis on chick embryo chorio-allantoic membrane. Zhongguo Zhong Xi Yi Jie He Za Zhi: 2005; 25 912 915
16. Zhang D. W., Liu J. G., Feng J. T., Zhang L., Yang X. P., Shi D. Z., Liang X. M. Effects of effective components compatibility of aqueous extracts of Salviae Miltiorrhizae and Rhizoma Chuanxiong on rat myocardial ischemia/reperfusion injury. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue: 2010; 22 109 112
17. Vanderheyden P. M., Fierens F. L., De Backer J. P., Fraeyman N., Vauquelin G. Distinction between surmountable and insurmountable selective AT1 receptor antagonists by use of CHO-K1 cells expressing human angiotensin II AT1 receptors. Br J Pharmacol: 1999; 126 1057 1065 (Pubitemid 29103724)
18. Maillard M. P., Perregaux C., Centeno C., Stangier J., Wienen W., Brunner H. R., Burnier M. In vitro and in vivo characterization of the activity of telmisartan: an insurmountable angiotensin II receptor antagonist. J Pharmacol Exp Ther: 2002; 302 1089 1095 (Pubitemid 34920230)
19. Zhang J. H., Chung T. D., Oldenburg K. R. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen: 1999; 4 67 73 (Pubitemid 29278954)
20. Moller H. J., Volz H. P., Reimann I. W., Stoll K. D. Opipramol for the treatment of generalized anxiety disorder: a placebo-controlled trial including an alprazolam-treated group. J Clin Psychopharmacol: 2001; 21 59 65 (Pubitemid 32096751)
21. Dedov V. N., Tran V. H., Duke C. C., Connor M., Christie M. J., Mandadi S., Roufogalis B. D. Gingerols: a novel class of vanilloid receptor (VR1) agonists. Br J Pharmacol: 2002; 137 793 798 (Pubitemid 35404178)
22. Clapham D. E. TRP channels as cellular sensors. Nature: 2003; 426 517 524 (Pubitemid 37522633)
23. Wang D. H. Transient receptor potential vanilloid channels in hypertension, inflammation, and end organ damage: an imminent target of therapy for cardiovascular disease? Curr Opin Cardiol: 2008; 23 356 363 (Pubitemid 351787101)
24. Shoji N., Iwasa A., Takemoto T., Ishida Y., Ohizumi Y. Cardiotonic principles of ginger (Zingiber officinale Roscoe). J Pharm Sci: 1982; 71 1174 1175 (Pubitemid 12032690)
25. Vasanthi H. R., Parameswari R. P. Indian spices for healthy heart - an overview. Curr Cardiol Rev: 2010; 6 274 279
26. Zick S. M., Ruffin M. T., Djuric Z., Normolle D., Brenner D. E. Quantitation of 6-, 8- and 10-Gingerols and 6-Shogaol in Human Plasma by High-Performance Liquid Chromatography with Electrochemical Detection. Int J Biomed Sci: 2010; 6 233 240
27. Carey R. M., Siragy H. M. Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation. Endocr Rev: 2003; 24 261 271 (Pubitemid 36733542)
28. Stanton A. Therapeutic potential of renin inhibitors in the management of cardiovascular disorders. Am J Cardiovasc Drugs: 2003; 3 389 394 (Pubitemid 38008675)
29. Mehta P. K., Griendling K. K. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol: 2007; 292 C82 C97 (Pubitemid 46127306)